The prevalence and clinical impact of reported cognitive difficulties (fibrofog) in patients with rheumatic disease with and without fibromyalgia.
about
Cognitive impairment in patients with fibromyalgia syndrome as assessed by the mini-mental state examinationIdentification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysisRestriction and elimination diets in ADHD treatmentOMERACT-based fibromyalgia symptom subgroups: an exploratory cluster analysisSynaptosomal-associated protein 25 (Snap-25) gene polymorphism frequency in fibromyalgia syndrome and relationship with clinical symptomsInfluence of craniosacral therapy on anxiety, depression and quality of life in patients with fibromyalgia.Neurobiology underlying fibromyalgia symptoms.Postural control deficits in people with fibromyalgia: a pilot study.The PedsQL as a patient-reported outcome in children and adolescents with fibromyalgia: an analysis of OMERACT domains.Development and initial validation of a brief self-report measure of cognitive dysfunction in fibromyalgia.Subjective memory complaints among patients on sick leave are associated with symptoms of fatigue and anxietyMilnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgiaFibromyalgia syndrome module at OMERACT 9: domain construct.Characterizing "fibrofog": Subjective appraisal, objective performance, and task-related brain activity during a working memory task.The Experience of Cognitive Intrusion of Pain: scale development and validationAnxiety, mood, and behavioral disorders among pediatric patients with juvenile fibromyalgia syndromeAssessing the Structure of the Ways of Coping Questionnaire in Fibromyalgia Patients Using Common Factor Analytic ApproachesCognitive performance in women aged 50 years and older with and without fibromyalgia.Neoteric pharmacotherapeutic targets in fibromyalgia.Fibrofog and fibromyalgia: a narrative review and implications for clinical practice.Fibromyalgia: A Critical and Comprehensive Review.Differential central pain processing following repetitive intramuscular proton/prostaglandin E₂ injections in female fibromyalgia patients and healthy controls.The cognitive impact of chronic low back pain: Positive effect of multidisciplinary pain therapy.Psychometric Properties of the Cognitive Emotion Regulation Questionnaire (CERQ) in Patients with Fibromyalgia Syndrome.Cognitive complaints in women with fibromyalgia: Are they due to depression or to objective cognitive dysfunction?Attentional deficits in fibromyalgia and its relationships with pain, emotional distress and sleep dysfunction complaints.Gratitude mediates quality of life differences between fibromyalgia patients and healthy controls.Implicit memory function in fibromyalgia syndrome.Association of physical fitness and fatness with cognitive function in women with fibromyalgia.Development of the Mental Clutter Scale.Spatial versus verbal memory impairments in patients with fibromyalgia.Longitudinal stability of fibromyalgia symptom clusters.Validity and reliability of community health activities model program for seniors and short-form international physical activity questionnaire as physical activity assessment tools in patients with fibromyalgia.Cognitive Impairments in Fibromyalgia Syndrome: Associations With Positive and Negative Affect, Alexithymia, Pain Catastrophizing and Self-Esteem.Executive function impairments in fibromyalgia syndrome: Relevance of clinical variables and body mass index.
P2860
Q33520094-81373604-270A-4ECE-8A42-0E9AF75DD074Q33618549-08D977DA-EFC3-4E33-B4AA-2DB7E4FB5BCCQ34438572-983C0CA1-1265-4AED-B101-D60505BF54FBQ34459831-4370EB57-1DFA-49C0-BCE8-BEB1578AF11CQ34500836-889FAF57-EDA5-4CC7-B04F-BFF03B9695C4Q35103943-0E6FBB3D-6061-41AF-9607-02926961309BQ35494751-3753526B-FFCB-4666-B7E4-29E394CB9A38Q35617687-C504678A-32EE-4CCA-AC6D-1803DA6DBEE9Q35645812-77C09F65-C630-47C0-8BA0-ED46B47BBA6BQ35685090-40871928-0C88-4F40-B557-CBEE3DCBC4BCQ36033474-31E587FA-FDE8-4292-8F08-9DE1CAD282AAQ36059500-CB0388BF-056D-4628-9D6A-5C4DA3CBA45CQ36165012-DC379909-1185-4A17-AD07-17F96329D5FBQ36601482-40DAF81D-DABC-4169-9510-6108CD863806Q36628438-C01A1411-5D2C-495C-ADF9-6D9A180445A5Q37011762-FCC47652-9053-4169-8D12-D2751F3C688CQ37533445-54E0AC6D-6D49-4EF1-9D0B-30CB9C9CCE39Q37685387-696EF808-3BEC-46C8-995F-FBF3805AD10EQ37929796-3D0840F6-D446-4791-8842-8C89793C0FBDQ38316188-6736F0CC-586F-424C-AB8D-95A9D14AE48EQ38601633-EABE6EA0-7B0C-42AE-8A68-034E582D3C27Q45043146-2E67FFCB-BCDA-472B-9E1B-A2705FB7E7A3Q47602196-9A380E9C-D56E-4006-B15E-0CFE5D278071Q47658814-8F6122C3-F46A-420E-BE46-1C07E2A1C395Q47753686-F9DFB61B-E2BE-4C71-9875-F9C63C790214Q48313056-9EACFAA7-1E9F-47BF-B314-80C78B182850Q48324677-D4CFB7C5-5CA3-4E48-9AF3-44AE2D991D55Q48520411-DAB82832-D604-4DCF-8A1B-B74AD17319D2Q50239716-DB817753-CAC0-4AC7-A93F-B2166802A5CEQ50773200-E2691F1E-504D-4DBF-807A-D145C65856A6Q51023162-90EC96AA-5A42-4EE4-AE3A-C60735FDC34AQ52682704-47194BA0-FF4A-4AFD-B3D5-275A06F35971Q53182575-E367B157-461A-489E-93D2-EDA668C51C20Q55236621-2895F3A8-6ED1-4D8A-9921-7C2DDDD7BC8FQ55252507-FBD2297E-8D17-410E-A9F1-8817989F4B02
P2860
The prevalence and clinical impact of reported cognitive difficulties (fibrofog) in patients with rheumatic disease with and without fibromyalgia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The prevalence and clinical im ...... with and without fibromyalgia.
@ast
The prevalence and clinical im ...... with and without fibromyalgia.
@en
type
label
The prevalence and clinical im ...... with and without fibromyalgia.
@ast
The prevalence and clinical im ...... with and without fibromyalgia.
@en
prefLabel
The prevalence and clinical im ...... with and without fibromyalgia.
@ast
The prevalence and clinical im ...... with and without fibromyalgia.
@en
P2093
P1476
The prevalence and clinical im ...... with and without fibromyalgia.
@en
P2093
Amy R Heard
Frank Leavitt
Megan Mills
Robert S Katz
P356
10.1097/01.RHU.0000120895.20623.9F
P577
2004-04-01T00:00:00Z